Assuntos
Hipercalcemia/complicações , Hiperparatireoidismo Primário/complicações , Complicações na Gravidez/patologia , Adulto , Feminino , Humanos , Hipercalcemia/diagnóstico por imagem , Hiperparatireoidismo Primário/diagnóstico por imagem , Gravidez , Complicações na Gravidez/diagnóstico por imagem , Tecnécio Tc 99m Sestamibi/químicaAssuntos
Nariz/fisiopatologia , Faringe/fisiopatologia , Apneia Obstrutiva do Sono/fisiopatologia , Traqueia/fisiopatologia , Adulto , Remodelação das Vias Aéreas , Criança , Anormalidades Craniofaciais/patologia , Anormalidades Craniofaciais/fisiopatologia , Progressão da Doença , Humanos , Obstrução Nasal/patologia , Obstrução Nasal/fisiopatologia , Nariz/patologia , Deformidades Adquiridas Nasais/patologia , Deformidades Adquiridas Nasais/fisiopatologia , Obesidade/patologia , Obesidade/fisiopatologia , Faringe/patologia , Rinite/patologia , Rinite/fisiopatologia , Fatores de Risco , Apneia Obstrutiva do Sono/diagnóstico , Apneia Obstrutiva do Sono/patologia , Traqueia/patologiaRESUMO
Androgen deficiency syndrome in men is a frequently diagnosed condition associated with clinical symptoms including fatigue, decreased libido, erectile dysfunction, and metabolic syndrome. Serum testosterone concentrations decline steadily with age. The prevalence of androgen deficiency syndrome in men varies depending on the age group, known and unknown comorbidities, and the respective study group. Reported prevalence rates may be underestimated, as not every man with symptoms of androgen deficiency seeks treatment. Additionally, men reporting symptoms of androgen deficiency may not be correctly diagnosed due to the vagueness of the symptom quality. The treatment of androgen deficiency syndrome or male hypogonadism may sometimes be difficult due to various reasons. There is no consensus as to when to start treating a respective man or with regards to the best treatment option for an individual patient. There is also lack of familiarity with treatment options among general practitioners. The formulations currently available on the market are generally expensive and dose adjustment protocols for each differ. All these factors add to the complexity of testosterone replacement therapy. In this article we will discuss the general indications of transdermal testosterone replacement therapy, available formulations, dosage, application sites, and recommended titration schedule.
Assuntos
Terapia de Reposição Hormonal , Testosterona/administração & dosagem , Administração Cutânea , Géis , Humanos , Hipogonadismo/diagnóstico , Masculino , Testosterona/efeitos adversos , Testosterona/fisiologiaRESUMO
INTRODUCTION: Somnambulism or sleepwalking is a disorder of arousal from non-rapid eye movement sleep. The prevalence of sleep-related eating disorder has been found to be approximately between 1% and 5% among adults. Many cases of medication-related somnambulism and sleep-related eating disorder-like behavior have been reported in the literature. Quetiapine, an atypical antipsychotic medication, has been associated with somnambulism but has not yet been reported to be associated with sleep-related eating disorder. CASE PRESENTATION: Case 1 is a 51-year-old obese African American male veteran with a body mass index of 34.11kg/m2 and severe sleep apnea who has taken 150mg of quetiapine at bedtime for more than one year for depression. He developed sleepwalking three to four nights per week which resolved after stopping quetiapine while being compliant with bi-level positive pressure ventilation therapy. At one year follow-up, his body mass index was 32.57kg/m2.Case 2 is a 50-year-old African American female veteran with a body mass index of 30.5kg/m2 and mild sleep apnea who has taken 200mg of quetiapine daily for more than one year for depression. She was witnessed to sleepwalk three nights per week which resolved after discontinuing quetiapine while being treated with continuous positive airway pressure. At three months follow-up, her body mass index was 29.1kg/m2. CONCLUSION: These cases illustrate that quetiapine may precipitate complex motor behavior including sleep-related eating disorder and somnambulism in susceptible patients. Atypical antipsychotics are commonly used in psychiatric and primary care practice, which means the population at risk of developing parasomnia may often go unrecognized. It is important to recognize this potential adverse effect of quetiapine and, to prevent injury and worsening obesity, discuss this with the patients who are prescribed these medications.
Assuntos
Pressão Positiva Contínua nas Vias Aéreas/efeitos adversos , Cooperação do Paciente , Apneia Obstrutiva do Sono/terapia , Pressão Positiva Contínua nas Vias Aéreas/instrumentação , Pressão Positiva Contínua nas Vias Aéreas/psicologia , Desenho de Equipamento , Humanos , Máscaras/efeitos adversos , Motivação , Ruído/prevenção & controle , Cooperação do Paciente/psicologia , Transtornos Fóbicos/prevenção & controleRESUMO
Non-invasive ventilation (NIV), the provision of ventilatory assistance without an artificial airway, has emerged as an important ventilatory modality over the last 20 years. Delivery of pressured air at a certain level through a nasal or oro-nasal mask improves oxygenation and reduces ventilatory muscle fatigue. The equipment consists of a ventilator (typically a CPAP or BiPAP machine) with tubing, headgear, nasal or facial mask, filter and humidifier (Figure 1). In this article, we will discuss the medical literatures that support the use of NIV safely and effectively on the general medical floor to treat respiratory failure secondary to acute exacerbation of chronic obstructive pulmonary disease (COPD) and congestive heart failure (CHF).
Assuntos
Respiração com Pressão Positiva/métodos , Insuficiência Respiratória/terapia , Insuficiência Cardíaca/complicações , Humanos , Doença Pulmonar Obstrutiva Crônica/complicações , Insuficiência Respiratória/etiologia , Fatores de RiscoAssuntos
Neoplasias/prevenção & controle , Queimadura Solar/prevenção & controle , Protetores Solares/efeitos adversos , Raios Ultravioleta , Deficiência de Vitamina D/induzido quimicamente , Deficiência de Vitamina D/tratamento farmacológico , Vitamina D/administração & dosagem , Feminino , Humanos , Masculino , GravidezRESUMO
Vitamin D deficiency is widely prevalent across all ages, races, geographical regions, and socioeconomic strata. In addition to its important role in skeletal development and calcium homeostasis, several recent studies suggest its association with diabetes, hypertension, cardiovascular disease, certain types of malignancy, and immunologic dysfunction. Here, we review the current evidence regarding an association between vitamin D deficiency and hypertension in clinical and epidemiological studies. We also look into plausible biological explanations for such an association with the renin-angiotensin-aldosterone system and insulin resistance playing potential roles. Taken together, it appears that more studies in more homogeneous study populations are needed before a firm conclusion can be reached as to whether vitamin D deficiency causes or aggravates hypertension and whether vitamin D supplementation is safe and exerts cardioprotective effects. The potential problems with bias and confounding factors present in previous epidemiological studies may be overcome or minimized by well designed randomized controlled trials in the future.